Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Advanced Research|August 24, 2023
Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoringYuzhen Gao, Shipeng Chen, Hao Wang, et al.
The Journal of General Virology|October 13, 2017
Next-generation sequencing revealed divergence in deletions of the preS region in the HBV genome between different HBV-related liver diseasesJian'an Jia, Xiaotao Liang, Shipeng Chen, et al.
International Journal of Biological Macromolecules|April 5, 2025
Discovery and interaction of four key biosynthetic enzymes under co-regulation for dopamine biosynthesis with marine Meyerozyma guilliermondii GXDK6 and Bacillus aryabhattai NM1-A2Huijie Sun, Ruihang Wei, Kailu Yin, et al.
Cells|October 14, 2022
The Emerging Roles and Clinical Potential of circSMARCA5 in CancerChangning Xue, Jianxia Wei, Mengna Li, et al.
International Journal of Biological Sciences|December 12, 2024
BRD7 enhances the radiosensitivity of nasopharyngeal carcinoma cells by negatively regulating USP5/METTL3 axis-mediated homologous recombination repairMengna Li, Jianxia Wei, Changning Xue, et al.
Frontiers in Oncology|April 21, 2023
Dissecting the roles and clinical potential of YY1 in the tumor microenvironmentMengNa Li, JianXia Wei, ChangNing Xue, et al.
Biomolecules|August 26, 2022
Let-7 as a Promising Target in Aging and Aging-Related Diseases: A Promise or a PledgeYa Wang, Juanjuan Zhao, Shipeng Chen, et al.
Plos One|September 28, 2023
NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunityLemei Zheng, Mengna Li, Jianxia Wei, et al.
Drug Design, Development and Therapy|April 29, 2024
Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver CancerShipeng Chen, Mengna Li, Changning Xue, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2025
Acid-activated mitochondria-targeting nanoprodrug for reactive oxygen species (ROS)-tolerant cancer therapy via antioxidant defense inhibitionZihao Teng, Chen Liu, Xiangfu Du, et al.
Pageof 8